Antifungal Resistance in Fungus Linked to Unique Gene Variant

Greg Howard
30th March, 2025

Antifungal Resistance in Fungus Linked to Unique Gene Variant

Confirming their shared essential function, the cyp51A gene from Madurella mycetomatis (Mm) and both the conserved (Mf1) and unique (Mf2) homologs from the drug-resistant Madurella fahalii successfully restored growth in a yeast strain whose native ERG11 gene was suppressed (+DOX).

Image adapted from: Yoshioka et al. / CC BY (Source)

Key Findings

  • In Sudan, Japanese researchers discovered that the fungus causing mycetoma has two genes making it resistant to the common antifungal drug itraconazole
  • One of these genes alters the drug’s target, helping the fungus survive treatment
  • This breakthrough can lead to better treatments and tests for resistant fungal infections
Mycetoma, a chronic and debilitating fungal infection, poses significant health challenges, particularly in regions like Sudan where it is prevalent. The most common culprit behind this infection is Madurella mycetomatis. However, another related species, Madurella fahalii, has emerged as a notable cause of eumycetoma. Unlike M. mycetomatis, M. fahalii shows resistance to itraconazole, the primary antifungal treatment used for eumycetoma, creating a pressing need to understand the mechanisms behind this resistance[2]. Researchers at Chiba University, Japan, have made significant strides in addressing this issue through their recent study[1]. By sequencing the high-quality draft genome of M. fahalii IFM 68171, the team uncovered two copies of the gene responsible for encoding cytochrome P450 14-α sterol demethylase (CYP51). This enzyme is the target of itraconazole, making it a crucial factor in the drug's effectiveness. The two identified genes include Mfcyp51A1, which is conserved among Madurella species, and Mfcyp51A2, a gene specific to M. fahalii. Both genes are actively expressed and show increased activity when exposed to itraconazole, suggesting a direct role in the organism's resistance. This discovery builds on previous knowledge about fungal resistance mechanisms. For instance, in Aspergillus fumigatus, mutations in the cyp51A gene have been linked to itraconazole resistance[3]. Similarly, broader studies have highlighted the complexity of antifungal resistance, emphasizing that successful treatment relies on understanding pathogen-specific resistance factors alongside host and drug-related variables[4]. The identification of an additional CYP51 gene in M. fahalii provides a specific genetic basis for its resistance, aligning with the broader understanding of how fungi adapt to antifungal therapies. To investigate the functional impact of the Mfcyp51A genes, the researchers conducted experiments using Saccharomyces cerevisiae, a common model organism in genetic studies. By introducing the Mfcyp51A2 gene into yeast cells, they observed a noticeable decrease in susceptibility to itraconazole compared to cells with the Mfcyp51A1 gene. This suggests that the presence of Mfcyp51A2 enhances the fungus's ability to withstand itraconazole treatment, likely by altering the drug's target enzyme in a way that reduces its efficacy. The implications of this study are significant for the treatment of eumycetoma. As prior research has shown, accurate species identification is crucial for selecting the most effective antifungal therapy[2]. The ability to distinguish M. fahalii from other Madurella species can inform healthcare providers about the potential resistance to itraconazole, allowing them to consider alternative treatments or combination therapies to manage the infection more effectively. Moreover, this research underscores the importance of genetic studies in understanding and combating antifungal resistance. While culture-based methods remain essential for identifying fungal pathogens, integrating molecular techniques, such as genome sequencing and gene expression analysis, can provide deeper insights into resistance mechanisms. This comprehensive approach is vital, given the diversity of mutations and resistance strategies that fungi can employ[4]. The findings from Chiba University also open new avenues for developing targeted therapies. By focusing on the specific genes that contribute to drug resistance, researchers can design inhibitors that specifically block these resistance mechanisms, potentially restoring the effectiveness of existing antifungal drugs. Additionally, understanding the regulation and expression of multiple CYP51 genes can lead to the development of diagnostic tools that quickly identify resistant strains, enabling more personalized and effective treatment plans. In conclusion, the discovery of an additional CYP51 gene in Madurella fahalii by researchers at Chiba University represents a significant advancement in our understanding of antifungal resistance in eumycetoma. This genetic insight not only explains the observed resistance to itraconazole but also provides a foundation for developing better diagnostic and therapeutic strategies. As the incidence of invasive fungal infections continues to rise and treatment options remain limited, studies like this are essential for improving patient outcomes and managing fungal diseases more effectively[2][4].

MedicineGeneticsMycology

References

Main Study

1) Itraconazole resistance in Madurella fahalii linked to a distinct homolog of the gene encoding cytochrome P450 14-α sterol demethylase (CYP51)

Published 27th March, 2025

https://doi.org/10.1371/journal.pntd.0012623

Related Studies

2) New species of Madurella, causative agents of black-grain mycetoma.

https://doi.org/10.1128/JCM.05477-11

3) Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.

Journal: The Journal of antimicrobial chemotherapy, Issue: Vol 55, Issue 1, Jan 2005

4) Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.

https://doi.org/10.1093/jac/dkac161


Related Articles

An unhandled error has occurred. Reload 🗙